MARÍA BEGOÑA PRIETO MOLANO-rekin lankidetzan egindako argitalpenak (9)

2023

  1. Comparison of the Administration of 150 or 75 IU of Recombinant LH in Agonist ICSI Cycles Stimulated with Recombinant FSH in Women Aged 35-39: A Comparative Study

    Journal of Reproduction and Infertility, Vol. 24, Núm. 4, pp. 269-278

2018

  1. Proteomic pattern of implantative human endometrial fluid in in vitro fertilization cycles

    Archives of Gynecology and Obstetrics, Vol. 297, Núm. 6, pp. 1577-1586

2014

  1. Failure of intrauterine insemination as rescue treatment in low responders with adequate HCG timing with no oocytes retrieved

    Reproductive BioMedicine Online, Vol. 29, Núm. 5, pp. 634-639

2013

  1. Hysteroscopic hydrosalpinx occlusion with Essure device in IVF patients when salpingectomy or laparoscopy is contraindicated

    European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 169, Núm. 1, pp. 54-59

  2. Prevention of ovarian hyperstimulation syndrome in GnRH agonist IVF cycles in moderate risk patients: Randomized study comparing hydroxyethyl starch versus cabergoline and hydroxyethyl starch

    European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 170, Núm. 2, pp. 439-443

2012

  1. Human chorionic gonadotropin (hCG) plasma levels at oocyte retrieval and IVF outcomes

    Journal of Assisted Reproduction and Genetics, Vol. 29, Núm. 10, pp. 1067-1071

2011

  1. Mid-follicular LH supplementation in women aged 35-39 years undergoing ICSI cycles: A randomized controlled study

    Reproductive BioMedicine Online, Vol. 22, Núm. S1, pp. S43-S51

2010

  1. Daily workload in the embryology laboratory and in vitro fertilization results

    Journal of Reproductive Medicine for the Obstetrician and Gynecologist, Vol. 55, Núm. 1-2, pp. 49-54

2009

  1. Mid-follicular LH supplementation in women aged 35-39 years undergoing ICSI cycles: A randomized controlled study

    Reproductive BioMedicine Online, Vol. 19, Núm. 6, pp. 879-887